Short interest in STRATA Skin Sciences, Inc. (NASDAQ:SSKN) down 25.7%

STRATA Skin Sciences, Inc. (NASDAQ:SSKN – Get Free Report ) saw a significant drop in short interest in September. Since September 15th, there was short interest totaling 2,600 shares, down 25.7% from its August 31st total of 3,500 shares. Based on an average daily volume of 24,800 shares, the short interest rate is currently 0.1 days. About 0.1% of the company’s shares are short-sold.

STRATA Skin Sciences stock down 7.8%

NASDAQ:SSKN traded down $0.25 on Friday, reaching $2.95. The stock had a trading volume of 19,090 shares compared to its average volume of 11,680. The company has a quick ratio of 0.92, a current ratio of 1.14, and a debt-to-equity ratio of 1.59. STRATA Skin Sciences has a 52-week low of $2.51 and a 52-week high of $7.10. The company’s fifty day moving average is $3.14 and its 200 day moving average is $3.71. The company has a market cap of $10.35 million, a PE ratio of -0.89 and a beta of 1.37.

STRATA Skin Sciences (NASDAQ:SSKN – Get Your Free Report ) last posted its earnings results on Wednesday, August 14th. The medical device company reported ($0.03) earnings per share for the quarter. STRATA Skin Sciences had a negative return on equity of 50.45% and a negative net margin of 25.40%. The firm had revenue of $8.44 million for the quarter. On average, equities research analysts expect that STRATA Skin Sciences will post -1 EPS for the current fiscal year.

Internal activity at STRATA Skin Sciences

In other STRATA Skin Sciences news, Director Uri Geiger bought 230,573 shares of the stock in a transaction on Monday, July 15th. The shares were purchased at an average cost of $3.14 per share, for a total transaction of $723,999.22. Following the completion of the acquisition, the director now owns 1,441,835 shares in the company, valued at approximately $4,527,361.90. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC’s website. In related news, CEO Dolev Rafaeli acquired 19,100 shares of the business’s stock in a transaction dated Monday, July 15th. The stock was bought at an average price of $3.14 per share, with a total value of $59,974.00. Following the transaction, the chief executive officer now directly owns 143,156 shares of the company’s stock, valued at $449,509.84. The transaction was disclosed in a legal filing with the SEC, which is available on the SEC’s website. Also, Director Uri Geiger bought 230,573 shares of STRATA Skin Sciences stock in a transaction dated Monday, July 15th. The stock was purchased at an average price of $3.14 per share, with a total value of $723,999.22. Following the completion of the acquisition, the director now owns 1,441,835 shares in the company, valued at $4,527,361.90. Disclosure for this purchase can be found here. 40.43% of shares are owned by corporate insiders.

Institutional inputs and outputs

An institutional investor recently lifted its position in shares of STRATA Skin Sciences. Azzad Asset Management Inc. ADV increased its holdings in STRATA Skin Sciences, Inc. (NASDAQ:SSKN – Free Report) by 289.5% in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 67,000 shares of the medical device company’s stock after acquiring an additional 49,800 shares during the period. Azzad Asset Management Inc. ADV owned about 0.19% of STRATA Skin Sciences worth $25,000 at the end of the most recent quarter. 32.43% of shares are currently held by institutional investors.

About STRATA Skin Sciences

(Get a free report)

STRATA Skin Sciences, Inc, a medical technology company, develops, markets and markets products for the treatment of dermatological conditions in the United States, Europe, the Middle East, Asia, Australia, South Africa and Central and South America. The company operates in two segments, Recurrent Dermatological Procedures and Equipment for Dermatological Procedures.

Featured stories

Get news and reviews for STRATA Skin Sciences Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for STRATA Skin Sciences and related companies with MarketBeat.com’s FREE daily email newsletter.